Your browser doesn't support javascript.
loading
Difficult diagnosis and localization of focal nesidioblastosis: clinical implications of ⁶⁸Gallium-DOTA-D-Phe¹-Tyr³-octreotide PET scanning
Annals of Surgical Treatment and Research ; : 51-55, 2016.
Article in English | WPRIM | ID: wpr-135116
ABSTRACT
Focal nesidioblastosis is a rare cause of endogenous hyperinsulinemic hypoglycemia in adults. Because it is difficult to localize and detect with current imaging modalities, nesidioblastosis is challenging for biliary-pancreatic surgeons. ⁶⁸Gallium-DOTA-D-Phe¹-Tyr³-octreotide PET scanning and ¹¹¹indium-pentetreotide diethylene triamine pentaacetic acid octreotide scanning may be superior to conventional imaging modalities in determining the localization of nesidioblastosis. We report the successful surgical treatment of a 54-year-old woman with focal hyperplasia of the islets of Langerhans, who experienced frequent hypoglycemic symptoms and underwent various diagnostic examinations with different results.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Octreotide / Islets of Langerhans / Nesidioblastosis / Positron-Emission Tomography / Diagnosis / Surgeons / Hyperplasia / Hypoglycemia Type of study: Diagnostic study Limits: Adult / Female / Humans Language: English Journal: Annals of Surgical Treatment and Research Year: 2016 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Octreotide / Islets of Langerhans / Nesidioblastosis / Positron-Emission Tomography / Diagnosis / Surgeons / Hyperplasia / Hypoglycemia Type of study: Diagnostic study Limits: Adult / Female / Humans Language: English Journal: Annals of Surgical Treatment and Research Year: 2016 Type: Article